{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:09:08Z","timestamp":1778458148569,"version":"3.51.4"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"DOI":"10.1186\/s12883-026-04845-1","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:05:54Z","timestamp":1774915554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coexistence of anti-GluK2 and anti-LGI1 antibodies in a patient with autoimmune encephalitis: a rare case report and literature review"],"prefix":"10.1186","volume":"26","author":[{"given":"Zhuqing","family":"Luan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuxia","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"4845_CR1","doi-asserted-by":"publisher","first-page":"e26659","DOI":"10.1016\/j.heliyon.2024.e26659","volume":"10","author":"Y Tian","year":"2024","unstructured":"Tian Y, et al. Coexistence of anti-NMDAR and anti-IgLON5 antibodies in an autoimmune encephalitis patient: The first case report. Heliyo. 2024;10:e26659. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26659.","journal-title":"Heliyo"},{"key":"4845_CR2","doi-asserted-by":"publisher","first-page":"1609389","DOI":"10.3389\/fimmu.2025.1609389","volume":"16","author":"X Zhang","year":"2025","unstructured":"Zhang X, Ma F, Geng Q, Luo C, Qu C. Case Report: Coexistence of anti-LGI1 and anti-mGluR2 antibodies in an autoimmune encephalitis patient. Front Immunol. 2025;16:1609389. https:\/\/doi.org\/10.3389\/fimmu.2025.1609389.","journal-title":"Front Immunol"},{"key":"4845_CR3","first-page":"584","volume":"28","author":"Xiang-Li","year":"2020","unstructured":"Xiang-Li. Zhi yi-He. Research Progress in Viral encephalitis with secondary autoimmune encephalitis. J Chin J Clin Neurosciences. 2020;28:584\u20139.","journal-title":"J Chin J Clin Neurosciences"},{"key":"4845_CR4","doi-asserted-by":"publisher","unstructured":"Nissen MS, Ryding M, Meyer M, Blaabjerg M. Autoimmune Encephalitis: Current Knowledge on Subtypes, Disease Mechanisms and Treatment. CNS & neurological disorders drug targets. (2020) 19, 584\u201398, https:\/\/doi.org\/10.2174\/1871527319666200708133103","DOI":"10.2174\/1871527319666200708133103"},{"key":"4845_CR5","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/s1474-4422(23)00083-2","volume":"22","author":"J Dalmau","year":"2023","unstructured":"Dalmau J, Graus F. Diagnostic criteria for autoimmune encephalitis: utility and pitfalls for antibody-negative disease. Lancet Neurol. 2023;22:529\u201340. https:\/\/doi.org\/10.1016\/s1474-4422(23)00083-2.","journal-title":"Lancet Neurol"},{"key":"4845_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/s1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391\u2013404. https:\/\/doi.org\/10.1016\/s1474-4422(15)00401-9.","journal-title":"Lancet Neurol"},{"key":"4845_CR7","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1212\/wnl.0000000000003173","volume":"87","author":"A Van Sonderen","year":"2016","unstructured":"Van Sonderen A, et al. Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up. Neurology. 2016;87:1449\u201356. https:\/\/doi.org\/10.1212\/wnl.0000000000003173.","journal-title":"Neurology"},{"key":"4845_CR8","doi-asserted-by":"publisher","first-page":"1500904","DOI":"10.3389\/fimmu.2024.1500904","volume":"15","author":"S Jesse","year":"2024","unstructured":"Jesse S, et al. Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitis. Front Immunol. 2024;15:1500904. https:\/\/doi.org\/10.3389\/fimmu.2024.1500904.","journal-title":"Front Immunol"},{"key":"4845_CR9","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.seizure.2021.07.005","volume":"91","author":"L Chen","year":"2021","unstructured":"Chen L, et al. Association between autoimmune encephalitis and epilepsy: Systematic review and meta-analysis. Seizure. 2021;91:346\u201359. https:\/\/doi.org\/10.1016\/j.seizure.2021.07.005.","journal-title":"Seizure"},{"key":"4845_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/ana.26098","volume":"90","author":"J Landa","year":"2021","unstructured":"Landa J, et al. Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2. Ann Neurol. 2021;90:101\u201317. https:\/\/doi.org\/10.1002\/ana.26098.","journal-title":"Ann Neurol"},{"key":"4845_CR11","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41583-018-0002-7","volume":"19","author":"AC Bostan","year":"2018","unstructured":"Bostan AC, Strick PL. The basal ganglia and the cerebellum: nodes in an integrated network. Nat Rev Neurosci. 2018;19:338\u201350. https:\/\/doi.org\/10.1038\/s41583-018-0002-7.","journal-title":"Nat Rev Neurosci"},{"key":"4845_CR12","doi-asserted-by":"publisher","unstructured":"Knight HM et al. GRIK4\/KA1 protein expression in human brain and correlation with bipolar disorder risk variant status. American journal of medical genetics. Part B, Neuropsychiatric genetics: the official publication of the International Society of Psychiatric Genetics. (2012) 159b, 21\u201329. https:\/\/doi.org\/10.1002\/ajmg.b.31248","DOI":"10.1002\/ajmg.b.31248"},{"key":"4845_CR13","doi-asserted-by":"publisher","unstructured":"Chen S et al. Anti-GluK2 Encephalitis in an Asian Child: A Case Report and Literature Review. ImmunoTargets and therapy. (2024) 13, 805\u201311, https:\/\/doi.org\/10.2147\/itt.S498345","DOI":"10.2147\/itt.S498345"},{"key":"4845_CR14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12883-025-04037-3","volume":"25","author":"Z Cheng","year":"2025","unstructured":"Cheng Z, et al. Anti-GluK2 antibody-positive autoimmune encephalitis concurrent with multiple myeloma: a case report. BMC Neurol. 2025;25:27. https:\/\/doi.org\/10.1186\/s12883-025-04037-3.","journal-title":"BMC Neurol"},{"key":"4845_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/ana.26098","volume":"90","author":"J Landa","year":"2021","unstructured":"Landa J, et al. Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2. Ann Neurol. 2021;90:101\u201317. https:\/\/doi.org\/10.1002\/ana.26098.","journal-title":"Ann Neurol"},{"key":"4845_CR16","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1523\/jneurosci.20-06-02175.2000","volume":"20","author":"K Chergui","year":"2000","unstructured":"Chergui K, Bouron A, Normand E, Mulle C. Functional GluR6 kainate receptors in the striatum: indirect downregulation of synaptic transmission. J neuroscience: official J Soc Neurosci. 2000;20:2175\u201382. https:\/\/doi.org\/10.1523\/jneurosci.20-06-02175.2000.","journal-title":"J neuroscience: official J Soc Neurosci"},{"key":"4845_CR17","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1093\/cid\/cit458","volume":"57","author":"A Venkatesan","year":"2013","unstructured":"Venkatesan A, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect diseases: official publication Infect Dis Soc Am. 2013;57:1114\u201328. https:\/\/doi.org\/10.1093\/cid\/cit458.","journal-title":"Clin Infect diseases: official publication Infect Dis Soc Am"},{"key":"4845_CR18","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1001\/jamaneurol.2021.3188","volume":"78","author":"M Nosadini","year":"2021","unstructured":"Nosadini M, et al. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis. JAMA Neurol. 2021;78:1333\u201344. https:\/\/doi.org\/10.1001\/jamaneurol.2021.3188.","journal-title":"JAMA Neurol"},{"key":"4845_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","volume":"12","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol. 2013;12:157\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1.","journal-title":"Lancet Neurol"},{"key":"4845_CR20","doi-asserted-by":"publisher","unstructured":"Kosmidis ML, Dalakas MC. Practical considerations on the use of rituximab in autoimmune neurological disorders. Therapeutic advances in neurological disorders. (2010) 3, 93\u2013105, https:\/\/doi.org\/10.1177\/1756285609356135","DOI":"10.1177\/1756285609356135"},{"key":"4845_CR21","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1056\/NEJMoa011795","volume":"346","author":"B Coiffier","year":"2002","unstructured":"Coiffier B, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:235\u201342. https:\/\/doi.org\/10.1056\/NEJMoa011795.","journal-title":"N Engl J Med"},{"key":"4845_CR22","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.7150\/ijbs.4679","volume":"8","author":"M Erta","year":"2012","unstructured":"Erta M, Quintana A, Hidalgo J. Interleukin-6, a major cytokine in the central nervous system. Int J Biol Sci. 2012;8:1254\u201366. https:\/\/doi.org\/10.7150\/ijbs.4679.","journal-title":"Int J Biol Sci"},{"key":"4845_CR23","doi-asserted-by":"publisher","unstructured":"Ratuszny D, et al. Case Report: Daratumumab in a Patient With Severe Refractory Anti-NMDA Receptor Encephalitis. Volume. 2020;11\u20132020. https:\/\/doi.org\/10.3389\/fneur.2020.602102.","DOI":"10.3389\/fneur.2020.602102"},{"key":"4845_CR24","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s00415-019-09585-6","volume":"267","author":"F Scheibe","year":"2020","unstructured":"Scheibe F, et al. Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis. J Neurol. 2020;267:317\u201323. https:\/\/doi.org\/10.1007\/s00415-019-09585-6.","journal-title":"J Neurol"},{"key":"4845_CR25","doi-asserted-by":"publisher","first-page":"120042","DOI":"10.1016\/j.jns.2021.120042","volume":"431","author":"JE Eaton","year":"2021","unstructured":"Eaton JE, Kleinholz-Owens P, Sriram S, Pawate S. Intrathecal methotrexate - Another tool for the treatment of refractory autoimmune encephalitis - Single institution cohort and literature review. J Neurol Sci. 2021;431:120042. https:\/\/doi.org\/10.1016\/j.jns.2021.120042.","journal-title":"J Neurol Sci"},{"key":"4845_CR26","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/s1474-4422(13)70069-3","volume":"12","author":"S Byrne","year":"2013","unstructured":"Byrne S, Jordan I, Redmond J. Prevalence and treatment of anti-NMDA receptor encephalitis. Lancet Neurol. 2013;12:424. https:\/\/doi.org\/10.1016\/s1474-4422(13)70069-3.","journal-title":"Lancet Neurol"},{"key":"4845_CR27","doi-asserted-by":"publisher","first-page":"156","DOI":"10.4103\/0366-6999.222327","volume":"131","author":"XZ Yang","year":"2018","unstructured":"Yang XZ, et al. Utility and Safety of Intrathecal Methotrexate Treatment in Severe Anti-N-methyl-D-aspartate Receptor Encephalitis: A Pilot Study. Chin Med J. 2018;131:156\u201360. https:\/\/doi.org\/10.4103\/0366-6999.222327.","journal-title":"Chin Med J"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-04845-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04845-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-04845-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,10]],"date-time":"2026-05-10T23:43:40Z","timestamp":1778456620000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-04845-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4845"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-04845-1","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"11 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Yantai Yuhuangding Hospital Affiliated to Qingdao University. Written informed consent for participation was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication of their clinical details and\/or clinical images was obtained from the patient. A copy of the consent form is available for review by the Editor of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"309"}}